NYSE:GMED • US3795772082
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.568B 53.35% | 2.519B 60.62% | 2.939B 16.65% | 3.254B 10.72% | 3.464B 6.45% | 3.711B 7.13% | 3.994B 7.63% | 4.242B 6.21% | |
| EBITDA YoY % growth | 346.583M 13.78% | 479.63M 38.39% | 814.556M 69.83% | 1.019B 25.10% | 1.097B 7.65% | 1.128B 2.83% | 1.504B 33.33% | 1.627B 8.18% | |
| EBIT YoY % growth | 201.85M -14.58% | 225.606M 11.77% | 537.714M 138.34% | 771.62M 43.50% | 852.46M 10.48% | 803.57M -5.74% | N/A | N/A | |
| Operating Margin | 12.87% | 8.95% | 18.30% | 23.71% | 24.61% | 21.65% | N/A | N/A | |
| EPS YoY % growth | 2.33 12.56% | 3.14 34.76% | 4.00 27.39% | 4.52 12.98% | 5.00 10.71% | 5.52 10.41% | 6.35 15.04% | 6.92 8.83% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.94 37.53% | 1.07 23.85% | 1.10 -7.03% | 1.12 -12.39% | 1.01 8.20% | 1.10 3.00% | 1.16 5.44% | 1.16 3.15% |
| Revenue Q2Q % growth | 748.37M 25.12% | 807.82M 8.38% | 816.24M 6.14% | 830.49M 0.49% | 785.32M 4.94% | 827.42M 2.43% | 860.58M 5.43% | 874.63M 5.31% |
| EBITDA Q2Q % growth | 229.8M 39.88% | 256.78M -1.19% | 264.69M -22.80% | 267.73M -41.56% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 167.21M 70.25% | 187.87M 52.53% | 209.41M 55.10% | 212.35M 17.12% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 1.28 52.38% | 1.17 | 0.11 | 9.18% |
| Q3 2025 Q2Q % growth | 1.18 42.17% | 0.80 | 0.38 | 47.79% |
| Q2 2025 Q2Q % growth | 0.86 14.67% | 0.77 | 0.09 | 11.60% |
| Q1 2025 Q2Q % growth | 0.68 -5.56% | 0.76 | -0.08 | -10.39% |
| Q4 2024 Q2Q % growth | 0.84 40.00% | 0.76 | 0.08 | 10.48% |
| Q3 2024 Q2Q % growth | 0.83 45.61% | 0.66 | 0.17 | 25.45% |
| Q2 2024 Q2Q % growth | 0.75 19.05% | 0.69 | 0.06 | 8.60% |
| Q1 2024 Q2Q % growth | 0.72 35.85% | 0.58 | 0.14 | 24.38% |
| Q4 2023 Q2Q % growth | 0.60 1.69% | 0.62 | -0.02 | -3.57% |
| Q3 2023 Q2Q % growth | 0.57 14.00% | 0.58 | -0.01 | -2.25% |
| Q2 2023 Q2Q % growth | 0.63 12.50% | 0.61 | 0.02 | 4.09% |
| Q1 2023 Q2Q % growth | 0.53 26.19% | 0.52 | 0.01 | 2.20% |
| Q4 2022 Q2Q % growth | 0.59 20.41% | 0.57 | 0.02 | 3.24% |
| Q3 2022 Q2Q % growth | 0.50 | 0.53 | -0.03 | -5.77% |
| Q2 2022 Q2Q % growth | 0.56 | 0.54 | 0.02 | 2.86% |
| Q1 2022 Q2Q % growth | 0.42 -14.29% | 0.48 | -0.06 | -11.98% |
| Q4 2021 Q2Q % growth | 0.49 -15.52% | 0.48 | 0.01 | 1.69% |
| Q3 2021 Q2Q % growth | 0.50 2.04% | 0.46 | 0.04 | 8.54% |
| Q2 2021 Q2Q % growth | 0.56 700.00% | 0.45 | 0.11 | 23.57% |
| Q1 2021 Q2Q % growth | 0.49 68.97% | 0.37 | 0.12 | 30.88% |
| Q4 2020 Q2Q % growth | 0.58 | 0.52 | 0.06 | 11.85% |
| Q3 2020 Q2Q % growth | 0.49 | 0.31 | 0.18 | 58.93% |
| Q2 2020 Q2Q % growth | 0.07 | -0.11 | 0.18 | 164.34% |
| Q1 2020 Q2Q % growth | 0.29 | 0.39 | -0.10 | -25.75% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 826.42M 25.73% | 815.11M | 11.31M | 1.39% |
| Q3 2025 Q2Q % growth | 769.048M 22.91% | 749.03M | 20.018M | 2.67% |
| Q2 2025 Q2Q % growth | 745.342M 18.37% | 756.65M | -11.308M | -1.49% |
| Q1 2025 Q2Q % growth | 598.121M -1.41% | 638.42M | -40.299M | -6.31% |
| Q4 2024 Q2Q % growth | 657.293M 6.61% | 656.24M | 1.053M | 0.16% |
| Q3 2024 Q2Q % growth | 625.705M 63.10% | 616.01M | 9.695M | 1.57% |
| Q2 2024 Q2Q % growth | 629.691M 115.93% | 627.65M | 2.041M | 0.33% |
| Q1 2024 Q2Q % growth | 606.666M 119.26% | 598.88M | 7.786M | 1.30% |
| Q4 2023 Q2Q % growth | 616.534M 124.60% | 620.2M | -3.666M | -0.59% |
| Q3 2023 Q2Q % growth | 383.639M 50.98% | 435.83M | -52.191M | -11.98% |
| Q2 2023 Q2Q % growth | 291.615M 10.63% | 285.32M | 6.295M | 2.21% |
| Q1 2023 Q2Q % growth | 276.688M 20.04% | 260.39M | 16.298M | 6.26% |
| Q4 2022 Q2Q % growth | 274.5M 9.80% | 282.2M | -7.7M | -2.73% |
| Q3 2022 Q2Q % growth | 254.1M 10.62% | 258.21M | -4.11M | -1.59% |
| Q2 2022 Q2Q % growth | 263.6M 5.02% | 264.58M | -980K | -0.37% |
| Q1 2022 Q2Q % growth | 230.5M 1.41% | 238.85M | -8.35M | -3.50% |
| Q4 2021 Q2Q % growth | 250M 7.11% | 248.39M | 1.61M | 0.65% |
| Q3 2021 Q2Q % growth | 229.7M 6.29% | 232.87M | -3.17M | -1.36% |
| Q2 2021 Q2Q % growth | 251M 68.57% | 229.98M | 21.02M | 9.14% |
| Q1 2021 Q2Q % growth | 227.3M 19.25% | 202.36M | 24.94M | 12.32% |
| Q4 2020 Q2Q % growth | 233.4M | 235.84M | -2.44M | -1.03% |
| Q3 2020 Q2Q % growth | 216.1M | 200.05M | 16.05M | 8.02% |
| Q2 2020 Q2Q % growth | 148.9M | 101.72M | 47.18M | 46.38% |
| Q1 2020 Q2Q % growth | 190.6M | 198.39M | -7.79M | -3.93% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 1.2% | 3.63% | 1.12% | 16.94% |
| Revenue | 0% | 1.18% | 0.22% | 2.67% |